Alyante Introduction Presentation

Trusted Partners for Innovation and Business Edge Presents

Wockhardt India & RoW Wockhardt US Wockhardt UK & Ireland Wockhardt France R&D Center 8 API Plants 8 Formulation Plants Finished Dosage Plant @ Morton Grove Finished Dosage Plant @ Wrexham, UK & Pinewood, Ireland 1 API Plant @ Quimper, France 1 Finished Dosage Plant @ Mazal, France 40 yrs of Experience & World class Capabilities Wockhardt Business Initiative

Pharma Value Chain Contract Research Clinical Development Contract Manufacturing time Product Profitability Alyante’s Service Area ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wockhardt’s Services Target Identification & Validation Compound Generation, Screening & Lead Optimization Preclinical BA / BE Human Trials API Mfg Formulation Mfg Manufacturing & Marketing Wockhardt Business Initiative

Alyante Advantage Lead Finalization Pre Clinical Clinical Trials Commercialized Growth Mature $ Costs Revenues Cost Reduction 1 st Alyante Adv Patent Extension 2 nd Alyante Adv Early to Market On Patent Off Patent Early to market Late to market Wockhardt Business Initiative

N O V E L T Y Chiral Resolution Stable & Novel Polymorphs Non Infringing Process NDDS Development Modified Release forms Dose Reduction / Optimization Strategies Targeted Drug Delivery Systems Creating a Patent Portfolio Maximize Innovations Patent Extension Services Isolation, Characterization & Synthesis of Impurities Wockhardt Business Initiative

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Chemical Capabilities Wockhardt Business Initiative

[object Object],[object Object],[object Object],[object Object],[object Object],Formulations Diversity Wockhardt Business Initiative

[object Object],[object Object],[object Object],[object Object],Formulations Diversity Wockhardt Business Initiative

[object Object],[object Object],Analytical Excellence Wockhardt Business Initiative

[object Object],[object Object],[object Object],Analytical Excellence Wockhardt Business Initiative

Bulk Active’s Manufacturing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wockhardt Business Initiative

Commercial API List Wockhardt Business Initiative    Clopidogrel Hydrochloride    Clopidogrel Bisulphate Form 1    Zoledronic Acid    Granisetron    Octreotide Acetate    Oxybutynine Hydrochloride    Ceftazidime for Injection    Sterile Ceftriaxime Sodium    Sterile Ceftriaxone Sodium    Cefuroxime Axetil Amorphous    Dextropropoxyphene Napsylate    Dextropropoxyphene Hydrochloride    Dextromethorphan Hydrobromide CEP EDMF USDMF Commercial APIs

Commercial API List (contd.) Wockhardt Business Initiative    D-Oxyphene Base    Epinephrine    Duloxetine    Donepezil    Ziprasidone HCl    Zonisamide    Zolpidem    Adenosine    Nicardipine    Felodipine    Captopril    Tamsulosin HCl CEP EDMF USDMF Commercial APIs

API List Under Development Wockhardt Business Initiative Tolterodine Tartrate Ropinirole Prasugrel Palonosetron Olanzapine Fesoterodine Fexofenadine Dronedarone Des venlafaxine Cefepime Aripiprazole Armodafinil APIs under development

Finished Dosage Manufacturing @ India Wockhardt Business Initiative

Finished Dosage Manufacturing ex-India Wockhardt Business Initiative

Biopharmaceutical Value Chain Manufacturing ,[object Object],[object Object],[object Object],[object Object],Regulatory ,[object Object],[object Object],[object Object],Commercial ,[object Object],[object Object],Concept to Commercialization Capabilities R & D 6 Biotech products developed rhu Insulin, r Erythropoeitin, rhu ins Glargine Wockhardt Business Initiative

The Project Philosophy ,[object Object],[object Object],[object Object],[object Object],BD BD & Team Customer Contact Point ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wockhardt Business Initiative

Alyante is… ,[object Object],[object Object],[object Object],[object Object],[object Object],… it’s about relationships … and an alliance beyond projects … and keeps you always ahead of the competition Excellence with Alyante! Wockhardt Business Initiative

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Alyante is To Serve our Partners Wockhardt Business Initiative

Why ? Seasoned Team to address all requirements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Broadest Spectrum of Infrastructure Extensive Regulatory Expertise ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],End to End Drug Development Partner Wockhardt Business Initiative

[object Object],Contact us @ Wockhardt Ltd Wockhardt Towers, 6 th Floor (Near National Stock Exchange) Bandra – Kurla Complex Bandra (E) Mumbai – 400 051 Maharashtra, India Phone: +91 22 2653 4444 Fax: +91 22 2653 4242 +91 22 6692 1196 www.wockhardt.com

Alyante Introduction Presentation

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

En vedette

En vedette (18)

Similaire à Alyante Introduction Presentation

Similaire à Alyante Introduction Presentation (20)

Dernier

Dernier (20)

Alyante Introduction Presentation